Genital Self-Image as a Component of Sexual Health: Relationship Between Genital Self-Image, Female Sexual Function, and Quality of Life Measures

2003 ◽  
Vol 29 (sup1) ◽  
pp. 11-21 ◽  
Author(s):  
Laura A. Berman ◽  
JENNIFER Berman ◽  
MARIE MILES ◽  
DAN POLLETS ◽  
JENNIFER ANN POWELL
Keyword(s):  
Quality Of Life ◽  
Sexual Health ◽  
Sexual Function ◽  
Female Sexual Function ◽  
Self Image ◽  
Quality Of Life Measures

Sexual function and quality-of-life-related problems during the menopausal period

2017 ◽  
Vol 23 (14) ◽  
pp. 1769-1780 ◽  
Author(s):  
Ebru Gozuyesil ◽  
Sule Gokyildiz Surucu ◽  
Sultan Alan
Keyword(s):  
Quality Of Life ◽  
Sexual Dysfunction ◽  
Sexual Function ◽  
Life Questionnaire ◽  
Female Sexual Function ◽  
Quality Of Life Questionnaire ◽  
Sexual Quality Of Life ◽  
Total Female ◽  
The Mean

This study aims to evaluate the relationship between the sexual functions and quality of life and the problems during menopausal period. This descriptive, cross-sectional study included a total of 317 women. The mean total Female Sexual Function Index score was 18.8 ± 8.7, while the mean total Sexual Quality of Life Questionnaire-Female score was 72.7 ± 13.7. Sexual dysfunction was found in 82 percent. There was a positive significant correlation between the total Female Sexual Function Index scores and total Sexual Quality of Life Questionnaire-Female scores ( p < 0.05). Our study results suggest that women do not often experience serious menopausal symptoms, but have sexual dysfunction with a moderate sexual quality of life.

scholarly journals The Effect Of Different Types Of Hysterectomy On Female Sexual Function And Quality Of Life

2013 ◽  
Vol 16 (3) ◽  
pp. A77
Author(s):  
M. Hock ◽  
S. Tóth ◽  
G. Hartmann ◽  
B. Hajnal ◽  
J. Kránicz ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Sexual Function ◽  
Female Sexual Function ◽  
Different Types

scholarly journals The Effect of Positive Airway Pressure Therapy on Sexual Life and Quality of Life in Women with Moderate or Severe Obstructive Sleep Apnea Syndrome

2020 ◽  
Keyword(s):  
Quality Of Life ◽  
Sleep Apnea ◽  
Sexual Function ◽  
Sleep Apnea Syndrome ◽  
Female Sexual Function ◽  
Obstructive Sleep ◽  
The Mean ◽  
Apnea Syndrome ◽  
Pre Treatment

Background and Aim: Obstructive sleep apnea syndrome (OSAS) negatively affects quality of life and causes erectile dysfunction in men. However, there are few studies examining the effects of OSAS on women’s sexual health. This study used validated measurement tools to evaluate whether the presence and severity of OSAS had an impact on female sexual function and if there was a change after 6 months of CPAP treatment. Scores were compared before and after CPAP in the same and between groups. Material and Method: The patients were divided into moderate and severe groups based on the Apnea-Hypopnea Index (AHI). The female patients included in the study were administered the Female Sexual Function Index (FSFI), and the Calgary sleep apnea quality of life index (SAQLI) questionnaires to evaluate their sexual function. After CPAP treatment for 6 months, FSFI, and SAQLI questionnaires were compared with the results before treatment. Results: Among study participants, 72 had severe and 76 had moderate OSAS. The mean age (standard deviation or SD) in the severe OSAS group was 40.97±5.65 years and in the moderate OSAS group was 35.46 ± 5.43 years (p < 0.001). Body mass indexes of the severe and moderate OSAS groups were 33.10 ± 3.33 kg/m2and 31.04 ± 3.42 kg/m2, respectively (p < 0.001). The mean Epworth scores (SD) of the severe and moderate OSAS groups were 11.45 ± 3.27 and 9.52 ± 3.31, respectively (p = 0.001). Based on FSFI scores, in the pre-treatment period, desire, lubrication, and satisfaction were significantly better in the moderate OSAS group. After treatment, only desire and satisfaction were significantly better in the moderate OSAS group. In both groups, after treatment, all parameters of the FSFI score were significantly better compared with the pretreatment values (p = 0.001). When SAQLI scores were compared, in the pre-treatment period, all parameters were significantly better in the moderate OSAS group. In both groups, after treatment, all parameters of the SAQLI score were significantly better compared with the pre-treatment values (p = 0.001). Conclusion: In women with severe and moderate OSAS, sexual functions and satisfaction levels were negatively associated with OSAS severity. Sexual functions and quality of life were significantly improved with effective treatment of OSAS.

scholarly journals Função sexual e qualidade de vida em mulheres climatéricas

2019 ◽  
Vol 20 (1) ◽  
pp. 101
Author(s):  
Laís Figuerêdo Meira ◽  
Karla Cavalcante Silva De Morais ◽  
Nayara Alves De Sousa ◽  
Juliana Barros Ferreira
Keyword(s):  
Quality Of Life ◽  
Sexual Function ◽  
World Health Organization ◽  
Female Sexual Function Index ◽  
World Health ◽  
Female Sexual Function ◽  
World Health Organization Quality ◽  
Organization Quality ◽  
Health Organization

Introdução: O climatério é um período marcado por transformações no corpo feminino, desse modo, diversos problemas como: redução da lubrificação vaginal, anorgasmia e dispareunia podem surgir ou se agravar e, como consequência, favorece uma diminuição na qualidade de vida. Objetivo: Analisar a relação da função sexual e a qualidade de vida em mulheres climatéricas. Métodos: Trata-se de um estudo observacional, de corte transversal, analítico. A coleta de dados foi realizada com 20 mulheres climatéricas com faixa etária de 38 a 60 anos. Como instrumentos foram utilizados questionários contendo dados sociodemográficos, o Female Sexual Function Index para avaliar a função sexual e o World Health Organization Quality of Life WHOQOL-BREF para analisar a qualidade de vida. Resultados: Foi observado que nas mulheres que possuem disfunção sexual no domínio excitação, a média está abaixo do ponto de corte, o que não ocorre com mulheres que não possuem disfunção (p = 0,03), o mesmo ocorre com os domínios orgasmo e satisfação. Na correlação da função sexual com a qualidade de vida, há significância estatística nos domínios físico (p = 0,023) e meio ambiente (p = 0,049). Conclusão: Constatou-se que nas mulheres que possuem uma qualidade de vida reduzida os impactos da disfunção sexual são maiores.Palavras-chave: climatério, menopausa, mulheres, saúde sexual, qualidade de vida.

scholarly journals Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial

2020 ◽  
Author(s):  
Mina Amiri ◽  
Fatemeh Nahidi ◽  
Razieh Bidhendi-Yarandi ◽  
Davood Khalili ◽  
Maryam Tohidi ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Polycystic Ovary Syndrome ◽  
Sexual Function ◽  
Oral Contraceptives ◽  
Polycystic Ovary ◽  
Menstrual Disorders ◽  
Ovary Syndrome ◽  
Randomized Controlled ◽  
Self Image

Abstract Background and objective A limited number of studies have evaluated the effects of oral contraceptives (OCs) on the quality of life (QOL) of polycystic ovary syndrome (PCOS) patients. This study aimed to compare the effects of using OCs containing levonorgestrel (LNG) and those containing desogestrel (DSG), cyproterone acetate (CPA) or drospirenone (DRSP) for 6 months on the QOL with PCOS. Methods In this crossover randomized controlled 6-arm trial, 200 eligible patients with PCOS scheduled for OC therapy were randomly assigned to one of the 6 study arms. All 6 arms include two 6-month treatment periods, one period with OCs containing LNG, and the other with each of the 3 OCs containing DSG, CPA, or DRSP. Outcomes of interest were the total score of QOL and its domains, which were assessed using a specific and valid health‐related quality of life questionnaire for PCOS, which is consisted of six domains, including psychosocial–emotional, self-image, fertility, sexual function, hirsutism, and obesity– menstrual disorders.Results Finally, a total of 88 patients were analyzed for this study. The results showed that use of OCs containing DSG, CPA, and DRSP for 3 months was not associated with significant differences in the total scores of QOL compared to those OCs containing LNG, whereas, after 6 months of treatment, patients treated with OCs containing CPA had more improvements in their total scores of QOL, in comparison to OCs containing LNG (P < 0.042). We found no significant differences in QoL domains, including psychosocial–emotional, self-image, fertility, sexual function, hirsutism, and obesity-menstrual disorders after 3- 6 months of treatment with DSG, CPA, or DRSP, compared to LNG. The sequence and period effects were not significant in any of the analyses at 3 and 6 months of treatment. The carry-over effect was not significant for most outcomes assessed. Conclusions This crossover study demonstrated non-inferiority of OCs with newer generation progestins on different domains of QOL, in comparison with older compounds, although usage of products containing CPA was significantly associated with more improvement in total QOL of PCOS patients, compared to those containing LNG after 6-month of treatment. Clinical Trial Registration Number: IRCT201702071281N2.

Sign in / Sign up

Export Citation Format

Share Document